{"name":"Cosmo Bioscience","slug":"cosmo-bioscience","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"globenewswire.com","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements - globenewswire.com","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQNVJpdWF3di1UY0UwREpDLUE5OU8ybDVwUk4zWkg1cldfOWdHLXhDYnJXRjlwOUJFak1tTXZHd1dyNnNPa3l2M0NTT0xiT3ZYXzVINUJrZkNFR2I5ZnE3R0ZxakY1Mmt5SUpkNnFpTExwQkhUaTNOMjBZeGo4R1lBdkdLa29hUmtwcU5rcA?oc=5","date":"2026-01-02","type":"pipeline","source":"Yahoo Finance","summary":"Are Robust Financials Driving The Recent Rally In Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Stock? - Yahoo Finance","headline":"Are Robust Financials Driving The Recent Rally In Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Stock?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQQlB0MTRaalNNZVotdER5RVQwdjJGR1ZEb0ZnQUVzYVI2am9HaVNGaVJxQmNpUEFta1M0bUJ2eWUzWFp1cmg2OUJic0dPODMxSzdwVmFYZ1V3UjIwd0d5TC1FMmlodERuNnpMTXcxNlM4VFc3NDZBbjJoY3hVYU9uenk2ZlRiOElGbkU0blRvVXR3TkczUFA5Zw?oc=5","date":"2025-12-03","type":"trial","source":"Fierce Pharma","summary":"Cosmo shares zoom with results from 2 male-pattern hair loss trials - Fierce Pharma","headline":"Cosmo shares zoom with results from 2 male-pattern hair loss trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNTzRqMkZJVUxwdklmSDR0aHAxWTFLQ0l0bFlzTFZOdTZlTFd1NEdINnhMLTJEeFVlNml5Q1htSzRsbkFZdzVMSndKMzF0VkdkSDdtR3JQSzF5OW5EQW0xbjdITlQ0bGpEWWQ3MlppV0RuY1lGSURZSzJoajNHYnFJWXNSSQ?oc=5","date":"2025-11-05","type":"deal","source":"pharmaphorum","summary":"Psychedelic merger to create AtaiBeckley completes - pharmaphorum","headline":"Psychedelic merger to create AtaiBeckley completes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOYmU1LVhTNFh4Rno3SHZFbzhOUWNPcXpCY0ZPTC1ybGpxYWE3WFVJUjdzX3F1c3ZBSFREUXNlTWRZVDdnSHBCM0o0RWtfMGRNaVE3TkV1ajdweHhxbXhMeW03cV9Udm9kN2FkeWtMeXFvTjZMNTZoVjNHaDBMNXhaWA?oc=5","date":"2025-10-08","type":"pipeline","source":"Yahoo Finance","summary":"Cosmo Pharmaceuticals N.V.'s (VTX:COPN) biggest owners are private companies who got richer after stock soared 5.6% last week - Yahoo Finance","headline":"Cosmo Pharmaceuticals N.V.'s (VTX:COPN) biggest owners are private companies who got richer after stock soared 5.6% last","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1WZV9wZTVvclByNU8wenF3WmtRUTNNdXc4MVE3WUJtMTd6RG54M2JWeGlNa0FrV05PVG1YbXU1SjJIYmdfMVQ3UHU3MVU2YkdYNTNoRzQtbE9xNW9PNVFicEQyX01zVkR1N0RFNVdNTkNraWxJc0Fr?oc=5","date":"2025-10-08","type":"regulatory","source":"The Korea News Plus","summary":"Hyundai Pharm to sell Cosmo product approved in South Korea - The Korea News Plus","headline":"Hyundai Pharm to sell Cosmo product approved in South Korea","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2024-12-04","type":"pipeline","source":"Medical Dialogues","summary":"Six Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel - Medical Dialogues","headline":"Six Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AJBVV95cUxOcWdtWlF4SU1sUzlOOXlKU2g1Yjh6YlYzS0ZYSlFuZHhubDhYd19Cc0V2NUFEcXlSeURLbkVzSHBSaWFEWFRKVnJKbFpkby1pa3VGR3k3UHlnOF9Gd1NlTk55WmlsQ0FMLTU4ZWNkUmF0azVRVGJYTnlaQ2g4bFFVeVI3djFZWXBNZ1BMT0MwTlVfdUZMeEZ6SW1pak1udWFHUldYLU9pemh2b0YxSGttRnBoZnd6SU9TOVl1cjAwcHRSaDRxSEQzaVBmVnFNdDFQMzhFRVNrOU9ONEdLTHB6ZDE3aGtqNTNRdF8tYXJYNWQ4cnRCVTR2cUtfa0IxVDZWa3FRa0h0UFUxMVJ5bFF0aVYybjNzb29nTWJISVEyU1g3aVhzSjRQNlV1cjJkV2FKRmd3TVVmR24wWjRrWUxOLXh6X1NqUmVMUUNIZFFxdEJTZ1ZoZmN6TFRVaWN3U0huc2tNdQ?oc=5","date":"2024-03-13","type":"deal","source":"Business Wire","summary":"Pharmaceutical and Biotechnology Royalty Rates Report and Directory 2024: Technology Licensed, License Fees, Upfront and Milestone Payments for Deals Signed Since 2020 - ResearchAndMarkets.com - Busin","headline":"Pharmaceutical and Biotechnology Royalty Rates Report and Directory 2024: Technology Licensed, License Fees, Upfront and","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxOSUZaS3JMSy1ENlI3V3cxay1NZlh3WTJkOGF1WnhmWjY5WEc2OWFOSjNtV1pXdmIxWEw2VzZYMzhuWndfVDBlN3NSTTM2YlA5YXlQYmNKTkRzTVRHei1xMGpnY19hUDdUakVma0l0M0JqLVVNUkxLWW9aQXZaTlp1alJSMWlzV3FIVjRwWERTOUN3UVBuTFpKY0drWkZrSzlOOXpnMTlhMlRYcm1XM3J1clM5TVBhSFhMejBPUlNCLXhFM3pWek10YzdvX0l6aHpzWGtB?oc=5","date":"2023-02-07","type":"pipeline","source":"Healio","summary":"Ritlecitinib, brepocitinib outperform placebo for treatment of moderate to severe UC - Healio","headline":"Ritlecitinib, brepocitinib outperform placebo for treatment of moderate to severe UC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOaUY1VHUyVXlQQjd6X1ZuZURyeEFRRXZ5eklMYmVYWDdhUzlkWDluTGtyUHphNkpwTW5UZkVMOFNHeG5qZkdIT3ViTjNUdHlkTnJxVWQwRjZla2pWZ3c0WjhxUExYbTE4eFBaSnUwamNEcjI2SmFtZlRYcTBhSUg4cExR?oc=5","date":"2021-03-01","type":"pipeline","source":"MedPage Today","summary":"Vedolizumab Tied to Lower Risk for Serious Infections in Ulcerative Colitis - MedPage Today","headline":"Vedolizumab Tied to Lower Risk for Serious Infections in Ulcerative Colitis","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}